您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (4): 79-86.doi: 10.6040/j.issn.1671-7554.0.2021.0199

• 临床医学 • 上一篇    下一篇

子宫腺肌病中差异基因筛选及Wilms tumor-1的表达

耿晨,杨阳,赵月,刘浩冉,晁岚   

  1. 山东大学齐鲁医院妇产科不孕不育诊疗中心, 山东 济南 250012
  • 发布日期:2021-04-30
  • 通讯作者: 晁岚. E-mail:qlszcl@163.com
  • 基金资助:
    国家自然科学基金(81571511);山东省重点研发计划项目(2019GSF107004)

Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis

GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan   

  1. Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China
  • Published:2021-04-30

PDF (PC)

278

摘要： 目的 从GEO数据库中筛选子宫腺肌病的差异基因,探讨威尔姆氏瘤基因-1(WT1)基因在子宫腺肌病中的表达。 方法 通过GEO数据库进行候选基因的筛选;对差异基因进行KEGG和GO富集分析;Western blotting技术检测腺肌病组和对照组中WT1蛋白质表达;实时定量聚合酶链反应(qRT-PCR)检测子宫腺肌病异位内膜组织(腺肌病组)和正常子宫内膜(对照组)的WT1 mRNA表达;免疫组织化学测定WT1基因在腺肌病组及对照组中的表达位置及表达水平。 结果 差异基因的KEGG和GO富集于转录因子活性,钙黏蛋白结合参与细胞间粘附、生长因子结合等过程。Western blotting技术显示,子宫腺肌病异位内膜组织中WT1蛋白质表达水平低于对照组正常子宫内膜组织(P=0.002)。qRT-PCR结果显示,子宫腺肌病异位内膜组织中WT1 mRNA表达水平低于对照组正常子宫内膜组织(P=0.003)。免疫组织化学染色显示,腺肌病组异位内膜组织中间质WT1染色水平低于对照组(P=0.001);腺肌病组异位内膜组织中腺体WT1染色水平高于对照组(P<0.001);腺肌病组异位内膜组织WT1总体染色水平低于对照组(P=0.003)。 结论 从GEO数据库筛选得到差异基因并进行KEGG和GO富集分析,WT1在子宫腺肌病异位子宫内膜差异表达可能在子宫腺肌病的发生发展中发挥作用。

关键词: 子宫腺肌病, GEO数据库分析, 差异基因, 富集分析, Wilms tumor-1 基因

Abstract: Objective To screen the differentially expressed genes(DEGs)in adenomyosis from the Gene Expression Omnibus(GEO)database and to explore the expression of Wilms tumor-1(WT1). Methods The candidate genes were screened in the GEO database. The DEGs underwent Kyoto Encyclopedia of Genes and Genomes(KEGG)and Gene Ontology(GO)enrichment. The protein and mRNA expressions of WT1 in adenomyosis group and control group were detected with Western blotting and real-time quantitative polymerase chain reaction(qRT-PCR), respectively. The expression position and expression of WT1 in adenomyosis group and control group were determined with immunohistochemical staining. Results KEGG and GO of DEGs were enriched in transcription factor activity, cadherin binding involved in cell-cell adhesion, growth factor binding and other processes. Western blotting and qRT-PCR showed that the protein and mRNA expressions of WT1 were lower in the adenomyosis group than in the control group(P=0.002, P=0.003). Immunohistochemical staining showed that the WT1 staining level in stroma was lower in the adenomyosis group than in the control group(P=0.001), while the WT1 staining level in epithelium was higher(P<0.001); the overall staining level of WT1 in the adenomyosis group was lower than that in the control group(P=0.003). Conclusion The DEGs are screened from the GEO database and underwent KEGG and GO enrichment and WT1 may be involved in the pathogenesis of adenomyosis.

Key words: Adenomyosis, GEO data analysis, Differentially expressed genes, Enrichment analysis, Wilms tumor-1 gene

中图分类号: 

  • R711.71
[1] Soave I, Wenger JM, Pluchino N, et al. Treatment options and reproductive outcome for adenomyosis-associated infertility [J]. Curr Med Res Opin, 2018, 34(5): 839-849.
[2] Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis [J]. Hum Reprod Update, 2019, 25(5): 592-632.
[3] Bourdon M, Oliveira J, Marcellin L, et al. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles [J]. Hum Reprod, 2021, 36(2): 349-357.
[4] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
[5] Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach [J]. Hum Reprod Update, 2020, 26(3): 392-411.
[6] Upson K, Missmer SA. Epidemiology of adenomyosis [J]. Semin Reprod Med, 2020, 38(2-03): 89-107.
[7] Matsushima T, Akira S, Yoneyama K, et al. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest [J]. Gynecol Endocrinol, 2020, 36(6): 521-524.
[8] Hadley D, Pan J, El-Sayed O, et al. Precision annotation of digital samples in NCBIs gene expression omnibus [J]. Sci Data, 2017, 4(170125): 1-11.
[9] Dai FF, Bao AY, Luo B, et al. Identification of differentially expressed genes and signaling pathways involved in endometriosis by integrated bioinformatics analysis [J]. Exp Ther Med, 2020, 19(1): 264-272.
[10] Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets—update [J]. Nucleic Acids Res, 2013, 41(Database issue): D991-D995.
[11] Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible [J]. Nucleic Acids Res, 2017, 45(D1): D362-D368.
[12] Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks [J]. Bioinformatics, 2005, 21(16): 3448-3449.
[13] Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists [J]. Nucleic Acids Res, 2009, 37(1): 1-13.
[14] Benagiano G, Brosens I. The history of endometriosis: identifying the disease [J]. Hum Reprod, 1991, 6(7): 963-968.
[15] Kobayashi H, Kishi Y, Matsubara S. Mechanisms underlying adenomyosis-related fibrogenesis [J]. Gynecol Obstet Invest, 2020, 85(1):1-12.
[16] Carrarelli P, Yen CF, Funghi L, et al. Expression of inflammatory and neurogenic mediators in adenomyosis [J]. Reprod Sci, 2017, 24(3): 369-375.
[17] Xu W, Song Y, Li K, et al. Quercetin inhibits adenomyosis by attenuating cell proliferation, migration and invasion of ectopic endometrial stromal cells [J]. Drug Des Devel Ther, 2020, 14: 3815-3826.
[18] 林雪艳, 李春艳, 侯小满, 等. PARP-1及EMT标志物在子宫腺肌病在位及异位内膜中的表达[J]. 山东大学学报(医学版), 2017, 55(9):36-40. LIN Xueyan, LI Chunyan, HOU Xiaoman, et al. Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis [J]. Journal of Shandong university(Health Sciences), 2017, 55(9): 36-40.
[19] Pronier E, Bowman RL, Ahn J, et al. Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis [J]. Blood, 2018, 132(12): 1265-1278.
[20] Hung YP, Fletcher CD, Hornick JL. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics [J]. Mod Pathol, 2016, 29(11): 1324-1334.
[21] Matsuzaki S, Canis M, Darcha C, et al. Expression of WT1 is down-regulated in eutopic endometrium obtained during the midsecretory phase from patients with endometriosis [J]. Fertil Steril, 2006, 86(3): 554-558.
[22] Bantounas I, Lopes FM, Rooney KM, et al. The miR-199a/214 cluster controls nephrogenesis and vascularization in a human embryonic stem cell model [J]. Stem Cell Reports, 2021, 16(1): 134-148.
[23] Zhang J, Tsoi H, Li X, et al. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signaling pathway through targeting the WTAP-WT1-TBL1 axis [J]. Gut, 2016, 65(9): 1482-1493.
[24] Han Y, Song C, Zhang T, et al. Wilms tumor 1(WT1)promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling [J]. Cell Cycle, 2020, 19(20): 2662-2675.
[25] Pishbin F, Ziamajidi N, Abbasalipourkabir R, et al. Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer [J]. Per Med, 2021, 18(1): 31-42.
[26] Scharnhorst V, van der Eb AJ, Jochemsen AG. WT1 proteins: functions in growth and differentiation [J]. Gene, 2001, 273(2): 141-161.
[27] Lu B, Chen Q, Zhang X, et al. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases [J]. Diagn Pathol, 2016, 11(1): 46. doi: 10.1186/s13000-016-0496-0.
[28] Artibani M, Sims AH, Slight J, et al. WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel [J]. Sci Rep, 2017, 7(45255): 1-15.
[29] Makrigiannakis A, Coukos G, Mantani A, et al. Expression of Wilms Tumor Suppressor Gene(WT1)in Human Endometrium: Regulation through Decidual Differentiation [J]. J Clin Endocrinol Metab, 2001, 86(12): 5964-5972.
[30] Parenti R, Perris R, Vecchio GM, et al. Immunohistochemical expression of Wilms tumor protein(WT1)in developing human epithelial and mesenchymal tissues [J]. Acta Histochem, 2013, 115(1): 70-75.
[31] Nishikawa T, Wojciak JM, Dyson HJ, et al. RNA Binding by the KTS Splice Variants of Wilms Tumor Suppressor Protein WT1 [J]. Biochemistry, 2020, 59(40): 3889-3901.
[32] Schumacher V, Gueler B, Looijenga LH, et al. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome [J]. Mol Reprod Dev, 2008, 75(9): 1484-1494.
[1] 王国云,潘臧钰. 子宫腺肌病动物模型研究进展[J]. 山东大学学报 (医学版), 2022, 60(7): 48-55.
[2] 颜磊,陈子江. 子宫腺肌病合并不孕的治疗[J]. 山东大学学报 (医学版), 2022, 60(7): 43-47.
[3] 陶国伟,王芳,董向毅,徐亚瑄,赵琳丽,胡蓓蓓. 子宫腺肌病的超声与MRI诊断及进展[J]. 山东大学学报 (医学版), 2022, 60(7): 56-65.
[4] 艾星子·艾里,郭铮宇,张晓霏. 子宫腺肌病高强度聚焦超声消融治疗研究进展[J]. 山东大学学报 (医学版), 2022, 60(7): 36-42.
[5] 易晓芳,黄季华. 子宫腺肌病的患者教育及全程管理[J]. 山东大学学报 (医学版), 2022, 60(7): 32-35.
[6] 张信美,徐萍. 子宫腺肌病的手术治疗策略[J]. 山东大学学报 (医学版), 2022, 60(7): 26-31.
[7] 冷金花,史精华. 子宫腺肌病的临床表现[J]. 山东大学学报 (医学版), 2022, 60(7): 1-5.
[8] 彭超,周应芳. 子宫腺肌病的药物治疗进展[J]. 山东大学学报 (医学版), 2022, 60(7): 20-25.
[9] 郭孙伟,刘惜时. 子宫腺肌病发病机制和病理生理研究进展[J]. 山东大学学报 (医学版), 2022, 60(7): 6-19.
[10] 徐歌,李青,张灿灿,田永杰. 子宫腺肌病组织及原代细胞中PARP-1、HIF-1α的表达及临床意义[J]. 山东大学学报 (医学版), 2022, 60(4): 55-61.
[11] 修德健,高正文,宋婷婷,崔楠,崔静,孙健平. 生物信息学方法分析与宫颈癌有关联的基因[J]. 山东大学学报 (医学版), 2022, 60(10): 99-109.
[12] 杨贵霞,徐阳,马明明,宋然,朱鹏飞. 宫腹腔镜联合治疗Robert子宫合并子宫腺肌病1例[J]. 山东大学学报 (医学版), 2021, 59(1): 122-124.
[13] 王冰玉,杨阳,晁岚. TOLL样受体4在15例子宫腺肌病中的表达及作用[J]. 山东大学学报 (医学版), 2020, 58(6): 47-52.
[14] 林雪艳,李春艳,侯小满,田永杰. PARP-1及EMT标志物在子宫腺肌病在位及异位内膜中的表达[J]. 山东大学学报（医学版）, 2017, 55(9): 36-40.
[15] 吴卢侃璇,朱珊,于金习,吕椿子,李明江. 程序性死亡因子-1及其配体-1在子宫腺肌病中的表达及意义[J]. 山东大学学报（医学版）, 2017, 55(10): 90-96.
Viewed
Full text
276
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 276

  From Others local
  Times 66 210
  Rate 24% 76%

Abstract
1152
Just accepted Online first Issue
0 0 1152
  From Others
  Times 1152
  Rate 100%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
[1] 孙维彤,邹伟伟,李爱国,席延伟,张娜. 脂质体粒径对促进托氟啶口服吸收的影响[J]. 山东大学学报(医学版), 2007, 45(6): 639 -642 .
[2] 于清梅,武玉玲,宋海岩,尹华伟,庄园 . p38丝裂原活化蛋白激酶在小鼠早期胚胎及围植入期子宫内膜的表达[J]. 山东大学学报(医学版), 2008, 46(2): 123 -127 .
[3] 张勇,叶静,郭新星,肖水清. 牙周膜牵张成骨快速移动牙牙髓中IL-8表达的变化[J]. 山东大学学报(医学版), 2008, 46(4): 379 -381 .
[4] 肖伟玲,林亚杰,牟东珍,孙萍,梁淑娟 . 分泌型人IL-1β表达载体的构建及在H7402细胞中的表达[J]. 山东大学学报(医学版), 2008, 46(2): 119 -122 .
[5] 高静,陈雯,张同霞,王小花,戴廷军,姚红,赵秀鹤,迟兆富,单培彦 . 颞叶癫痫大鼠海马线粒体细胞色素氧化酶亚基Ⅲ和Ⅳ表达的变化[J]. 山东大学学报(医学版), 2007, 45(8): 817 -820 .
[6] . 干细胞标记物LGR5在结直肠癌发生发展中的表达及意义[J]. 山东大学学报(医学版), 2009, 47(8): 85 -88 .
[7] 杨奎忠,孙雪飞,项继顺,杜庆聪,黄凤昌 . c-FLIP反义寡核苷酸对食管癌EC109细胞裸鼠移植瘤抑制作用的实验研究[J]. 山东大学学报(医学版), 2007, 45(12): 1234 -1238 .
[8] 俞新爽,韩俊庆,王兴文,盛巍,王瑜. 乳腺癌患者细胞免疫水平与预后危险因素的关系及临床意义[J]. 山东大学学报(医学版), 2007, 45(9): 934 -937 .
[9] 于渊1,李岩1,荣风年2,梁婧1,刘晓琳1,王福立1. 自体CIK细胞治疗对卵巢癌调节性T细胞的影响[J]. 山东大学学报(医学版), 2010, 48(5): 101 -104 .
[10] 王海峰,史本康,张克勤,李永智,朱耀丰,王海新. B超检测的精索静脉直径及返流与术后精液质量的关系[J]. 山东大学学报(医学版), 2007, 45(7): 751 -752 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发